Nat Habit raises ₹142 million in Series C round led by Trident Growth Partners
Read more
YourStory [india, en]
yourstory.com

Nat Habit raises ₹142 million in Series C round led by Trident Growth Partners

The Indian natural cosmetics brand Nat Habit has successfully raised ₹142 crore in a Series C funding round. Trident Growth Partners led this round.

Existing investors, including Bertelsmann India Investments, Mirabilis Investment Trust, and Sharrp Ventures, participated in the investment round, along with new participants—Physis Capital and Hero Family Office.

The capital raised will be used by the company to expand its product range, strengthen manufacturing and formulation capabilities, and scale distribution through both quick commerce platforms and offline retail channels.

Nat Habit was founded in 2019 by Swagatik Das and Gaurav Agarwal. According to the company, the brand's annual gross revenue reached ₹330 crore.

Swagatik Das, co-founder of Nat Habit, noted that the brand was launched with the conviction that natural cosmetics should never force consumers to compromise on freshness or efficacy. This principle defined their path—from developing proprietary formulas to creating a brand that integrates the benefits of Ayurveda into daily self-care.

According to Nat Habit, the brand has created a unique selling proposition by combining traditional Ayurvedic principles with modern scientific developments. These fresh formulations are produced using the company's own research and production facilities. The company's portfolio covers hair care, skin care, body care, and baby cosmetics.

Currently, Nat Habit aims to move beyond major urban markets by expanding its presence in second-tier and lower-tier markets.

Atul Gupta, Managing Partner at Trident Growth Partners, stated that the Indian personal hygiene market is transforming, and consumers are increasingly seeking fully natural products they can trust for the whole family. He emphasized that Nat Habit has built an attractive business around the concept of 'Fresh Ayurveda,' offering natural benefits in daily care through advanced in-house research, development, and manufacturing.

Trident Growth Partners is a private growth-stage private equity firm headquartered in Bengaluru. The company supports leading founder-led businesses across consumer, financial services, corporate technology, manufacturing, and healthcare sectors.

Similar stories

Bestmed announces average contribution increase of 7.35% in 2027 and expansion of preventive care
Read more
iol.co.za

Bestmed announces average contribution increase of 7.35% in 2027 and expansion of preventive care

Bestmed has announced changes to its benefits plan for 2027, which include an average weighted contribution increase of 7.35% and an expansion of preventive healthcare coverage for members.

The medical scheme stated that these changes are due to member feedback, as well as rising healthcare and living expenses. Leo Dlamini, CEO and Chief Officer of Bestmed Medical Scheme, noted that households in South Africa continue to face pressure from the rising cost of living amid the downturn in global and local economic processes, which affects family finances.

He added that healthcare is a key element of this financial equation. Therefore, the scheme's approach for 2027 involved studying stakeholder feedback and making changes that provide greater choice, strengthen preventive care, and deliver more value while protecting the Scheme's long-term sustainability.

New Best Bucks Benefit

A new benefit called Best Bucks is being introduced, which will provide eligible members with R1000 per family after completing the Tempo lifestyle screenings. These funds can be used to pay for suitable consultations, radiology, and pathology before claims are paid from medical savings or other daily benefits.

Bestmed stated that this benefit aims to motivate members to undergo medical check-ups while providing additional funding for specific medical expenses. Furthermore, in 2027, the scheme is implementing several changes in preventive care.

These changes include coverage for respiratory syncytial virus (RSV) antibodies for infants across all options, pediatric vaccinations under Beat1, and a monthly maternity supplement of R151 under Beat2. Members in the Beat, Pace, and Rhythm2 ranges will have access to two postnatal consultations. Women over 45 in the Pace 1 range will also be able to undergo bone density screening every 24 months.

Bestmed clarified that HPV vaccination will also be extended to men. Infants born between January and May will also receive RSV protection during the infection season. The scheme reported that these preventive care benefits will be funded from the risk pool, according to the rules of the respective benefit option, and not from member savings or daily allowances.

The company noted that the 2027 offering is built on a strong position, as the Scheme continues to grow, maintaining a stable risk profile and a high solvency ratio of 37.3%, significantly exceeding the statutory minimum of 25%.

Popular